Generics - Actavis

Filter

Current filters:

Actavis

Popular Filters

82 to 106 of 1247 results

Actavis to shed another business, its Actavis Foshan unit in China

Actavis to shed another business, its Actavis Foshan unit in China

26-01-2014

US generics major Actavis revealed a second divestiture this month, saying it has signed and completed…

ActavisAsia-PacificChinaGenericsMergers & AcquisitionsZhejiang Chiral

Another ban by US FDA on a Ranbaxy production facility

Another ban by US FDA on a Ranbaxy production facility

24-01-2014

As if the Indian drug major has not had enough negative news from the US regulator, the US Food and Drug…

Asia-PacificDaiichi SankyoGenericsIndiaNorth AmericaProductionRanbaxy LaboratoriesRegulationUSA

Proposed US legislation on biosimilars welcomed by BIO and WBBA

Proposed US legislation on biosimilars welcomed by BIO and WBBA

23-01-2014

The USA’s Biotechnology Industry Organization (BIO) and the Washington Biotechnology & Biomedical Association…

BiosimilarsGenericsLegalNorth AmericaRegulationUSA

Actavis confirms challenge to Allergan’s Restasis

22-01-2014

Generics drug major Actavis has confirmed that its Watson Laboratories unit has submitted an Abbreviated…

ActavisAllerganGenericsNorth AmericaOphthalmicsPatentsRegulationRestasisUSAWatson Pharmaceuticals

Par Pharmaceutical to acquire JHP Pharmaceutical

21-01-2014

US privately-held Par Pharmaceutical has entered into a definitive agreement to acquire JHP Group Holdings,…

GenericsJHP PharmaceuticalsMergers & AcquisitionsPar Pharmaceutical

Actavis to divest certain European operations to Aurobindo

Actavis to divest certain European operations to Aurobindo

18-01-2014

US generics major Actavis plans to enter into an agreement with India’s Aurobindo Pharma for the latter…

ActavisAurobindo PharmaEuropeGenericsMergers & Acquisitions

Alvogen takes 67% stake in Lotus Pharma

17-01-2014

Privately-owned US generics firm Alvogen revealed that, last month, it agreed to become the majority…

AlvogenAsia-PacificGenericsLotus PharmaceuticalsMergers & Acquisitions

Celltrion’s trastuzumab biosimilar, Herzuma, approved in South Korea

16-01-2014

South Korean biopharmaceutical firm Celltrion has received approval for its cancer treatment biosimilar…

Asia-PacificBiosimilarsCellTrionGenericsHerceptinHerzumaOncologyRegulationRoche

Actavis restructures, appointing industry veterans to lead US Specialty Brands business units

Actavis restructures, appointing industry veterans to lead US Specialty Brands business units

14-01-2014

US generics and specialty drugmaker Actavis has announced an updated business structure for its US Specialty…

ActavisBoardroomGenericsManagement

Amneal appoints former Warner Chilcott senior VP Rochelle Fuhrmann as CFO

14-01-2014

Privately-held US generics drugmaker Amneal has announced Rochelle Fuhrmann has joined the company as…

Amneal PharmaBoardroomGenericsUSAWarner Chilcott

J&J’s Janssen units file Citizen Petition with FDA on biosimilars naming

J&J’s Janssen units file Citizen Petition with FDA on biosimilars naming

09-01-2014

Health care giant Johnson & Johnson’s Janssen Pharmaceutical companies have submitted a Citizen Petition…

BiosimilarsGenericsJanssenJohnson & JohnsonNorth AmericaRegulationUSA

Teva confirms appointment of Erez Vigodman as president and CEO

Teva confirms appointment of Erez Vigodman as president and CEO

09-01-2014

Somewhat sooner than expected, Isael’s Teva Pharmaceutical Industries, the world’s largest generics…

BoardroomGenericsManagementTeva Pharmaceutical Industries

Ranbaxy cleared to market branded generic of Aricept in Canada

Ranbaxy cleared to market branded generic of Aricept in Canada

08-01-2014

The Canadian subsidiary of Ranbaxy Laboratories has received approval to manufacture and market RAN-Donepezil…

AriceptCanadaDaiichi SankyoEisaiGenericsNeurologicalNorth AmericaRAN-DonepezilRanbaxy LaboratoriesRegulation

US national health spending growth remains low for 4th consecutive year

07-01-2014

Overall national health expenditures in the USA grew at an annual rate of 3.7% in 2012, marking the fourth…

FinancialGenericsHealthcareNorth AmericaPharmaceuticalUSA

Teva looks set to name Erez Vigodman as new CEO

Teva looks set to name Erez Vigodman as new CEO

07-01-2014

Speculation is mounting that Israel’s Teva Pharmaceutical Industries is about to appoint a new chief…

BoardroomGenericsManagementPharmaceuticalTeva Pharmaceutical Industries

Amneal debuts generic Esomeprazole strontium in USA

07-01-2014

Privately-held US generics drugmaker Amneal Pharmaceuticals has announced the launch of generic esomeprazole…

Amneal PharmaAstraZenecaEsomeprazole MagnesiumGastro-intestinalsGenericsMarkets & MarketingNexiumNorth AmericaUSA

Teva launches authorized generic of Detrol in USA

Teva launches authorized generic of Detrol in USA

04-01-2014

Israel’s Teva Pharmaceutical Industries, the world’s largest generic drugmaker, says it has launched…

Detrol LAGenericsGenito-urinaryMarkets & MarketingNorth AmericaPfizerTeva Pharmaceutical IndustriesUSA

Mylan hires Rakesh Bamzai as president, India commercial and emerging markets

Mylan hires Rakesh Bamzai as president, India commercial and emerging markets

04-01-2014

US drugmaker Mylan says that Rakesh Bamzai has joined the company and has been appointed president, India…

BoardroomGenericsManagementMylan Laboratories

US FTC rescheduled workshop on state regulations and naming conventions set for February

31-12-2013

The US Federal Trade Commission announced its one-day public workshop on competition and follow-on biologics,…

BiosimilarsGenericsMarkets & MarketingNorth AmericaRegulationUSA

Nissan Chemical and Kowa to sue generic drugmakers over Livalo patent infringements

30-12-2013

With the commencement this year of manufacturing and selling generic copies of the hypercholesterolemia…

Asia-PacificCardio-vascularGenericsKowaLegalLivaloNissan ChemicalPatents

US Office of Generic Drugs reorganization

US Office of Generic Drugs reorganization

29-12-2013

The US Food and Drug Administration’s Center for Drug Evaluation and Research has approved plans to…

GenericsNorth AmericaRegulationUSA

Hepalink to acquire USA’s Scientific Protein Laboratories

27-12-2013

China’s Shenzhen Hepalink Pharmaceutical has entered into a stock purchase agreement to acquire USA-based…

GenericsheparinMergers & AcquisitionsScientific Protein LaboratoriesShenzhen Hepalink Pharmaceutical

ANI Pharma buys 31 generic drugs from Teva

ANI Pharma buys 31 generic drugs from Teva

27-12-2013

Emerging US generic drugmaker ANI Pharmaceuticals says that it has acquired 31 previously marketed generic…

ANI PharmaceuticalsGenericsMergers & AcquisitionsTeva Pharmaceutical Industries

82 to 106 of 1247 results

Back to top